Cefnimax S 500 mg/250 mg Injection
By Cefnimax S
Rx
1 Injection in a Vial

Composition
Cefotaxime(500mg) + Sulbactam(250mg)

Manufacturer - Parenteral Drugs India Ltd
Shree Ganesh Chambers, Navlakha Crossing, A.B. Road, Indore 452001 Mandhya Pradesh (INDIA)

Expires on or after
October, 2025

liver
Limited information is present regarding the use of Cefnimax S 500 mg/250 mg Injection in individuals with liver ailments. It is strongly recommended to seek guidance from your healthcare provider before administering this medication to ensure its safety and appropriateness for your specific condition.

kidney
Cefnimax S 500 mg/250 mg Injection needs caution in patients with kidney disease. Dose adjustment may be required. Consult your doctor for advice. Monitor your kidney function regularly while on this medication.

alcohol
When taking Cefnimax S 500 mg/250 mg Injection, it is important to be cautious when consuming alcohol. It is recommended to consult your doctor regarding alcohol intake with this medication.

driving
Cefnimax S 500 mg/250 mg Injection may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if these effects are experienced.

pregnancy
Cefnimax S 500 mg/250 mg Injection is generally safe to use during pregnancy based on animal studies, which showed minimal harm to the baby. Limited human studies are available.

breastfeeding
Cefnimax S 500 mg/250 mg Injection is safe to use during breastfeeding. Studies show it doesn't pass into breastmilk in harmful amounts, posing no risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹19.36
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024